Stony Brook University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1957-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.stonybrook.edu
Prospective Randomized Trial of Moderate vs Deep Neuromuscular Blockade During Laparoscopic Ventral Hernia Repair
Not Applicable
- Conditions
- PneumoperitoneumNeuromuscular BlockadeHernia, Ventral
- First Posted Date
- 2017-06-28
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 34
- Registration Number
- NCT03201744
- Locations
- 🇺🇸
Shabana Humayon, Stony Brook, New York, United States
Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines
- Conditions
- Heart FailureBreast CancerBiomarkersEchocardiographyCardiotoxicityAnthracycline Induced Cardiomyopathy
- First Posted Date
- 2017-05-16
- Last Posted Date
- 2019-11-01
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 35
- Registration Number
- NCT03155802
- Locations
- 🇺🇸
Stony Brook Medicine, Stony Brook, New York, United States
Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue
- Conditions
- Pancreatic AdenocarcinomaPancreatic CystPancreatic Cancer
- First Posted Date
- 2017-05-04
- Last Posted Date
- 2021-03-19
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 300
- Registration Number
- NCT03140592
- Locations
- 🇺🇸
Stony Brook University, Stony Brook, New York, United States
Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)
Phase 1
Completed
- Conditions
- Alcohol Abstinence
- Interventions
- Drug: Placebo (for guanfacine)
- First Posted Date
- 2017-05-02
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 32
- Registration Number
- NCT03137082
- Locations
- 🇺🇸
The Health Sciences Center, Stony Brook, New York, United States
General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial
Phase 4
Completed
- Conditions
- Anesthesia, GeneralSurgical Oncology
- Interventions
- Drug: Volatile Agent
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 1826
- Registration Number
- NCT03034096
- Locations
- 🇺🇸
Roswell Park Cancer Center, Buffalo, New York, United States
🇺🇸Long Island Jewish Medical Center, New Hyde Park, New York, United States
🇺🇸Icahn School of Medicine at Mount Sinai, New York, New York, United States
Transcranial Direct Current Stimulation (tDCS) in Post-Stroke Working Memory Deficits
Not Applicable
Terminated
- Conditions
- Short-Term Memory ImpairmentStrokeCognitive DeficitCognitive Impairment
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2017-10-23
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 5
- Registration Number
- NCT03034109
- Locations
- 🇺🇸
Stony Brook University, Stony Brook, New York, United States
A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Not Applicable
Terminated
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-01-13
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 12
- Registration Number
- NCT03020797
- Locations
- 🇺🇸
Stony Brook University Medical Center, Stony Brook, New York, United States
ME/CFS: Activity Patterns and Autonomic Dysfunction
- Conditions
- Chronic Fatigue Syndrome
- First Posted Date
- 2016-10-28
- Last Posted Date
- 2016-11-03
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 150
- Registration Number
- NCT02948556
- Locations
- 🇺🇸
Stony Brook University, Stony Brook, New York, United States
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
Phase 4
- Conditions
- Superimposed PreeclampsiaEclampsiaHELLP SyndromeToxemiaGestational Hypertension
- Interventions
- First Posted Date
- 2016-09-30
- Last Posted Date
- 2017-10-05
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 412
- Registration Number
- NCT02920593
- Locations
- 🇺🇸
SUNY Stony Brook Hospital, Stony Brook, New York, United States
VO2 Max: In Vivo Model for Functional Red Cell Testing. Can RECESS be Explained?
Phase 4
Completed
- Conditions
- Healthy
- First Posted Date
- 2016-09-29
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 42
- Registration Number
- NCT02918851
- Locations
- 🇺🇸
Stony Brook Medicine, Stony Brook, New York, United States